title: Chapter 2-3. Anaerobic infections (individual fields): central nervous system infections (brain abscess, subdural abscess, epidural abscess and bacterial meningitis).
mesh_terms: D000038:Abscess / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001421:Bacteria, Anaerobic / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*; D001424:Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D001922:Brain Abscess / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D002493:Central Nervous System Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D020802:Epidural Abscess / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D013355:Subdural Space / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents